Radek Horvath, Partner and Investor

Professional Overview

Radek Horvath is an experienced partner and investor with a diverse background in the life sciences and biotechnology industries. He brings a wealth of expertise in quality assurance, research and development, and executive leadership to his current roles.

Experience Summary

Current Roles

As a Partner and Investor at 22 Hor Invest, Radek is responsible for evaluating and managing investment opportunities in promising start-ups and emerging companies. He also serves as a Member of the Board of Directors at ALPCO HOLDINGS LLC in Salem, New Hampshire, and as a Member of the Supervisory Board at GeneProof a.s.

Career Progression

Radek's career spans over two decades in the life sciences industry. He previously served as the CEO and Founder of GeneProof a.s., where he led the company's research and development efforts as Head of Quality Assurance and Quality Control. Prior to that, Radek held roles as a Manager of Research and Development at Bioveta, a.s. and as a Clinical Microbiologist at Fakultní nemocnice u sv. Anny v Brně (FNUSA) - St. Anne's University Hospital Brno / FNUSA-ICRC.

Academic Background

Radek holds a relevant academic background, though specific details are not provided in the information given.

Areas of Expertise

Radek's areas of expertise include quality assurance, research and development, and executive leadership in the life sciences and biotechnology industries. He has demonstrated proficiency in navigating the complexities of the healthcare and pharmaceutical sectors.

Professional Impact

Throughout his career, Radek has contributed significantly to the advancement of the life sciences industry. His leadership and technical expertise have driven the success of the organizations he has been involved with, and his current roles as a partner and investor allow him to leverage his experience to identify and support promising opportunities in the field.

Conclusion

Radek Horvath is a seasoned professional with a proven track record of success in the life sciences and biotechnology industries. His diverse experience, technical expertise, and leadership skills position him as a valuable partner and investor, poised to contribute to the growth and innovation of the sector.